KYTHERA BIOPHARMACEUTICALS INC·4

Feb 12, 2:42 PM ET

Walker Patricia S 4

4 · KYTHERA BIOPHARMACEUTICALS INC · Filed Feb 12, 2013

Insider Transaction Report

Form 4
Period: 2013-01-29
Walker Patricia S
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2013-01-29+20,10020,100 total
    Exercise: $27.50Exp: 2023-01-29Common Stock (20,100 underlying)
  • Award

    Stock Option (right to buy)

    2013-01-29+13,40013,400 total
    Exercise: $27.50Exp: 2023-01-29Common Stock (13,400 underlying)
Footnotes (2)
  • [F1]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2013 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
  • [F2]The shares subject to the option shall vest upon the achievement of certain performance milestones, as approved by the Issuer's Board of Directors. None of the shares subject to the option are currently vested or exercisable.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -